1. Home
  2. AMBO vs VIVS Comparison

AMBO vs VIVS Comparison

Compare AMBO & VIVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ambow Education Holding Ltd.

AMBO

Ambow Education Holding Ltd.

N/A

Current Price

$2.87

Market Cap

8.1M

Sector

Real Estate

ML Signal

N/A

Logo VivoSim Labs Inc.

VIVS

VivoSim Labs Inc.

HOLD

Current Price

$2.02

Market Cap

8.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMBO
VIVS
Founded
2000
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.1M
8.1M
IPO Year
2010
N/A

Fundamental Metrics

Financial Performance
Metric
AMBO
VIVS
Price
$2.87
$2.02
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
23.3K
35.2K
Earning Date
08-05-2025
02-18-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.69
N/A
Revenue
$9,699,000.00
$140,000.00
Revenue This Year
N/A
$42.38
Revenue Next Year
N/A
$15.42
P/E Ratio
$4.10
N/A
Revenue Growth
23.73
35.92
52 Week Low
$1.59
$1.41
52 Week High
$6.75
$21.96

Technical Indicators

Market Signals
Indicator
AMBO
VIVS
Relative Strength Index (RSI) 40.20 48.73
Support Level $2.70 $1.96
Resistance Level $3.00 $2.29
Average True Range (ATR) 0.33 0.15
MACD 0.02 0.02
Stochastic Oscillator 27.72 51.60

Price Performance

Historical Comparison
AMBO
VIVS

About AMBO Ambow Education Holding Ltd.

Ambow Education Holding Ltd is an AI-driven technology educational company. Along with its subsidiaries, the company is developing a new HybriU AI Digital Education Solution that transforms the educational environment, bridging the gap between traditional methods and the future of digital learning. The solution combines sophisticated software and hardware to create an AI-powered digital and hybrid classroom, designed to enhance educational delivery and engagement. In addition, the group offers high-quality, individualized, and dynamic career education services and products through the operation of its for-profit colleges. Substantially the majority of the group's revenues are derived from the United States, based on the geographical locations where services are provided to customers.

About VIVS VivoSim Labs Inc.

VivoSim Labs Inc formerly, Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data. FXR is a mediator of gastrointestinal and liver diseases. It is now offering liver toxicology predictive screening and research services as well as working on predicting and studying the intestinal side effect profiles of drugs that are therapeutic candidates of pharmaceutical and biotech companies at all stages of drug development.

Share on Social Networks: